Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms.

Jastrzebskal, M

Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms. [electronic resource] - Nutrition, metabolism, and cardiovascular diseases : NMCD Oct 2004 - 259-69 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0939-4753

10.1016/s0939-4753(04)80053-x doi


Adult
Analysis of Variance
Angiotensin-Converting Enzyme Inhibitors--therapeutic use
Antihypertensive Agents--therapeutic use
Fibrinogen--drug effects
Genetic Predisposition to Disease
Hemostasis--genetics
Humans
Hypertension--blood
Male
Peptidyl-Dipeptidase A--drug effects
Perindopril--therapeutic use
Phenotype
Plasminogen Activator Inhibitor 1--genetics
Polymorphism, Genetic
Treatment Outcome